NO158950C - Dna-sekvens som koder for et polypeptid med human fibroblast-interferonaktivitet, fremgangsmaate for dens fremstilling, samt fremgangsmaate for fremstilling av et plasmid. - Google Patents

Dna-sekvens som koder for et polypeptid med human fibroblast-interferonaktivitet, fremgangsmaate for dens fremstilling, samt fremgangsmaate for fremstilling av et plasmid.

Info

Publication number
NO158950C
NO158950C NO803230A NO803230A NO158950C NO 158950 C NO158950 C NO 158950C NO 803230 A NO803230 A NO 803230A NO 803230 A NO803230 A NO 803230A NO 158950 C NO158950 C NO 158950C
Authority
NO
Norway
Prior art keywords
procedure
manufacturing
plasmid
polypeptide
dna sequence
Prior art date
Application number
NO803230A
Other languages
English (en)
Norwegian (no)
Other versions
NO803230L (no
NO158950B (no
Inventor
Haruo Sugano
Masami Muramatsu
Tadatsugu Taniguchi
Original Assignee
Japan Found Cancer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP13928979A external-priority patent/JPS5663996A/ja
Priority claimed from JP3393180A external-priority patent/JPS56131598A/ja
Application filed by Japan Found Cancer filed Critical Japan Found Cancer
Publication of NO803230L publication Critical patent/NO803230L/no
Publication of NO158950B publication Critical patent/NO158950B/no
Publication of NO158950C publication Critical patent/NO158950C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/565—IFN-beta

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
NO803230A 1979-10-30 1980-10-29 Dna-sekvens som koder for et polypeptid med human fibroblast-interferonaktivitet, fremgangsmaate for dens fremstilling, samt fremgangsmaate for fremstilling av et plasmid. NO158950C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP13928979A JPS5663996A (en) 1979-10-30 1979-10-30 Novel recombinant having gene complementary to human interferon messenger rna
JP3393180A JPS56131598A (en) 1980-03-19 1980-03-19 Novel recombinant plasmid having gene of human fibroblastic interferon messenger rna

Publications (3)

Publication Number Publication Date
NO803230L NO803230L (no) 1981-05-04
NO158950B NO158950B (no) 1988-08-08
NO158950C true NO158950C (no) 1988-11-16

Family

ID=26372701

Family Applications (1)

Application Number Title Priority Date Filing Date
NO803230A NO158950C (no) 1979-10-30 1980-10-29 Dna-sekvens som koder for et polypeptid med human fibroblast-interferonaktivitet, fremgangsmaate for dens fremstilling, samt fremgangsmaate for fremstilling av et plasmid.

Country Status (8)

Country Link
EP (1) EP0028033B1 (de)
AU (1) AU538665B2 (de)
CA (1) CA1341563C (de)
DE (1) DE3071435D1 (de)
DK (1) DK458480A (de)
ES (3) ES496426A0 (de)
IL (1) IL61366A (de)
NO (1) NO158950C (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5554513A (en) * 1979-11-21 1996-09-10 Yeda Research & Development Co. Ltd. Production of recombinant human interferon-beta2
US5510472A (en) * 1979-11-21 1996-04-23 Yeda Research And Development Co. Ltd. Production of recombinant human interferon-beta2
US6835557B1 (en) 1980-01-08 2004-12-28 Biogen, Inc. DNA sequences, recombinant DNA molecules and processes for producing human interferon-like polypeptides
CY1346A (en) * 1980-01-08 1987-01-16 Biogen Nv Dna sequences,recombinant dna molecules and processes for producing human interferon-like polypeptides
DK33181A (da) * 1980-02-06 1981-08-07 Searle & Co Fremgangsmaade til fremstilling af et interferonlignende protein
DE3005843A1 (de) * 1980-02-16 1981-09-10 Hoechst Ag, 6000 Frankfurt Genprodukt eines hoeheren organismus aus einem dieses gen enthaltenden mikroorganismus
DE3005897A1 (de) * 1980-02-16 1981-09-03 Hoechst Ag, 6000 Frankfurt Genprodukt eines hoeheren organismus aus einem dieses gen enhtaltenden mikroorganismus
DE3177213D1 (de) 1980-04-03 1990-10-18 Biogen Inc Dns-sequenzen, rekombinante dns-molekuele und verfahren zur herstellung von dem menschlichen fibroblast-interferon.
FR2490675B1 (fr) * 1980-09-25 1985-11-15 Genentech Inc Production microbienne d'interferon de fibroplaste humain
DE3280127D1 (de) * 1981-03-27 1990-04-12 Ici Plc Genetisch modifizierte mikroorganismen.
IL65475A0 (en) * 1981-04-17 1982-07-30 Meloy Lab Production of immune interferon and its mrna
GB2108510B (en) * 1981-10-03 1984-12-12 Ciba Geigy Ag Dnas, recombinant dnas, hosts containing them, polypeptides and processes for the production thereof
AU561343B2 (en) * 1981-10-19 1987-05-07 Genentech Inc. Human immune interferon by recombinant dna
US5582824A (en) * 1981-10-19 1996-12-10 Genentech, Inc. Recombinant DES-CYS-TYR-CYS human immune interferon
US4450103A (en) * 1982-03-01 1984-05-22 Cetus Corporation Process for recovering human IFN-β from a transformed microorganism
US5827694A (en) * 1982-03-08 1998-10-27 Genentech, Inc. DNA encoding non-human animal interferons, vectors and hosts therefor, and recombinant production of IFN polypeptides
US6936694B1 (en) 1982-05-06 2005-08-30 Intermune, Inc. Manufacture and expression of large structural genes
DE3220116A1 (de) * 1982-05-28 1983-12-01 Dr. Karl Thomae Gmbh, 7950 Biberach Mikrobiologisch hergestellte (alpha)- und ss-interferone, dna-sequenzen, die fuer diese interferone codieren, mikroorganismen, die diese genetische information enthalten, und verfahren zu ihrer herstellung
US4588585A (en) * 1982-10-19 1986-05-13 Cetus Corporation Human recombinant cysteine depleted interferon-β muteins
US4737462A (en) * 1982-10-19 1988-04-12 Cetus Corporation Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of interferon-β
US5831023A (en) * 1982-11-01 1998-11-03 Genentech, Inc. Recombinant animal interferon polypeptides
US4518584A (en) * 1983-04-15 1985-05-21 Cetus Corporation Human recombinant interleukin-2 muteins
US4855238A (en) 1983-12-16 1989-08-08 Genentech, Inc. Recombinant gamma interferons having enhanced stability and methods therefor
US5425940A (en) * 1986-04-09 1995-06-20 Cetus Oncology Corporation Combination therapy using interleukin-2 and tumor necrosis factor
ES2074420T3 (es) 1986-04-15 1995-09-16 Ciba Geigy Ag Anticuerpos monoclonales contra proteina humana inducida por interferon en forma pura y kits de ensayo que contienen dichos anticuerpos.
US4961969A (en) * 1987-05-11 1990-10-09 Cetus Corporation Process for recovering microbially produced interferon-β
DE4010797A1 (de) * 1990-04-04 1991-10-10 Hoechst Ag Substituierte azole, verfahren zu deren herstellung, diese enthaltende mittel und deren verwendung
FR2686899B1 (fr) 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
GB9506051D0 (en) 1995-03-24 1995-05-10 Univ Singapore Gene expression
DK1017413T4 (da) 1997-09-23 2008-03-25 Rentschler Biotech Gmbh Flydende formulering af interferon-beta
EP1274720A4 (de) 2000-04-12 2004-08-18 Human Genome Sciences Inc Albumin enthaltende fusionsproteine
US6887462B2 (en) 2001-04-09 2005-05-03 Chiron Corporation HSA-free formulations of interferon-beta
PT1463751E (pt) 2001-12-21 2013-08-26 Human Genome Sciences Inc Proteínas de fusão de albumina
CA2513213C (en) 2003-01-22 2013-07-30 Human Genome Sciences, Inc. Albumin fusion proteins
DK3321359T3 (da) 2005-04-11 2021-03-08 Horizon Pharma Rheumatology Llc Variante former af uratoxidase og anvendelse deraf
WO2008051178A2 (en) 2006-04-12 2008-05-02 Savient Pharmaceuticals, Inc. Purification of proteins with cationic surfactant
US8273561B2 (en) 2007-10-05 2012-09-25 Nuron Biotech, Inc. High pressure treatment of aggregated interferons
RU2535038C2 (ru) 2009-06-25 2014-12-10 Криэлта Фармасьютикалз ЭлЭлСи Способы и наборы для прогнозирования риска инфузионных реакций и опосредованной антителами потери ответа при терапии пэгилированной уриказой с помощью мониторинга содержания мочевой кислоты в сыворотке крови
DE102009032179A1 (de) 2009-07-07 2011-01-13 Biogenerix Ag Verfahren zur Reinigung von Interferon beta
US20200237881A1 (en) 2019-01-30 2020-07-30 Horizon Pharma Rheumatology Llc Reducing immunogenicity to pegloticase
EP3538135A4 (de) 2016-11-11 2020-07-29 Horizon Pharma Rheumatology LLC Kombinationstherapien von prednison- und uricase-molekülen und deren verwendung
US12269875B2 (en) 2023-08-03 2025-04-08 Jeff R. Peterson Gout flare prevention methods using IL-1BETA blockers

Also Published As

Publication number Publication date
ES8303530A1 (es) 1983-02-01
ES8203102A1 (es) 1982-02-16
EP0028033A3 (en) 1981-08-19
EP0028033A2 (de) 1981-05-06
DK458480A (da) 1981-05-01
EP0028033B1 (de) 1986-02-19
ES507596A0 (es) 1983-02-01
IL61366A0 (en) 1980-12-31
AU6376280A (en) 1981-05-07
NO803230L (no) 1981-05-04
DE3071435D1 (en) 1986-03-27
NO158950B (no) 1988-08-08
IL61366A (en) 1983-11-30
ES8303529A1 (es) 1983-02-01
CA1341563C (en) 2007-12-04
ES496426A0 (es) 1982-02-16
ES507595A0 (es) 1983-02-01
AU538665B2 (en) 1984-08-23

Similar Documents

Publication Publication Date Title
DE3071435D1 (en) Double-stranded dna which codes for a polypeptide with human fibroblast interferon activity, cloned dna, recombinant plasmid containing the dna and microorganism containing the recombinant plasmid
DE3689246D1 (de) Physiologisch aktives Polypeptid BUF-3.
DK184887A (da) Stol med leddelt, boejeligt fjederrygstoed
NO854165L (no) Stol.
FI851336L (fi) Ny fysiologiskt aktiv human polypeptid.
NO892834D0 (no) Imidoperoksikarboksylsyrer, dens fremstilling og anvendelse.
IT8619338A0 (it) Peptide sintetico ad attivita'interleukina 1 umana.
DE3786767D1 (de) Neues polypeptid.
FI871124L (fi) Polypeptid, dna och dess anvaendning.
DK143492D0 (da) Human-h2-praeprorelaxin, -prorelaxin og -relaxin samt polypeptid med relaxinaktivitet
FI844289A7 (fi) Uusia polypeptidejä, joilla on -amylaasi-estävä vaikutus, niiden käyttö ja farmaseuttiset valmistee
DE3850019D1 (de) Rekombinantes Avipoxvirus.
NO161154C (no) Stol uten rygg for korrigering av sittestilling.
IT8505195A0 (it) Nuovo gene beta-urogastrone, corrispondenti plasmidi ricombinanti, corrispondenti trasformanti e metodo per lapreparazione di questi e del beta-urogastrone.
DE3885313D1 (de) Peptide mit Laminin-Wirksamkeit.
FI841288A0 (fi) Rekombinant-dna-kod foer uttryckning av polypeptid.
DK509985D0 (da) Antibiotisk polypeptid, fremgangsmaade til dets fremstilling samt dets anvendelse
FI885296L (fi) Rekombinant hiv-2 polypeptid.
DK97485A (da) Spergualin-beslaegtede forbindelser med en phenylengruppe, fremgangsmaade til fremstilling deraf samt deres anvendelse som laegemidler
NO853400L (no) Polypeptidvaksiner.
DE3886517D1 (de) Menschlicher Prourokinase ähnliches Polypeptid.
NO862533L (no) Beslag for stol, saerlig kontorstol.
NO854903L (no) Peptidvaksine eller -diagnosemiddel, samt polypeptid for slik anvendelse.
FI861428A7 (fi) Rekombinoitu ihmisreniini.
FI862734A7 (fi) Uudet polypeptidit, joilla on kasvutekijäaktiivisuutta ja nukleiinihap posekvenssit, jotka koodaavat polypeptidejä.